Spinocerebellar Ataxia Type 1 With Axonal Neuropathy

Neurology·MeSH: Neglected Diseases

Prevalence

5.0 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Spinocerebellar Ataxia Type 1 With Axonal Neuropathy?

There are 1 clinical trial targeting Spinocerebellar Ataxia Type 1 With Axonal Neuropathy tracked by BioSniper.

What is the prevalence of Spinocerebellar Ataxia Type 1 With Axonal Neuropathy?

The estimated prevalence of Spinocerebellar Ataxia Type 1 With Axonal Neuropathy is approximately 5.0 per 100,000 population.

Deep-dive into Spinocerebellar Ataxia Type 1 With Axonal Neuropathy

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Spinocerebellar Ataxia Type 1 With Axonal Neuropathy — Drugs in Development & Clinical Trials | BioSniper